AndreaBozzo/ceres-open-data-index huggingface dataset:
Evaluation of Child Care Subsidy Strategies: Massachusetts Family Child Care Study, 2005-2007

The Massachusetts Family Child Care study is a two-year evaluation, conducted by Abt Associates Inc, the Manpower Development Research Corporation (MDRC) and the National Center for Children in Poverty (NCCP), of the impacts of the LearningGames program on providers and children in family child care. LearningGames is designed to train caregivers to stimulate children's cognitive, language, and social-emotional development through a set of 200 simple games that encourage intensive, one-on-one interactions as a platform that allows the adult to engage the child in meaningful conversation, to listen to the child and respond to the child's questions and actions, and to scaffold and build on the child's growing skills at using and understanding language. The goal of LearningGames is to increase the frequency of rich language interactions between caregivers and children due to the importance of oral language development in children's understanding of words and concepts, in their ability to become competent readers, and in their long-term academic success and of the role played by rich language stimulation in promoting children's development. This evaluation of LearningGames examines the effectiveness of the program in changing the behavior of the family child care providers and the developmental outcomes for the children who are cared for by providers trained on LearningGames.

<b>Units of Response: </b>Massachusetts child care providers.

<b>Type of Data: </b>Administrative

<b>Tribal Data: </b>No

<b>Periodicity: </b>One-time

<b>Demographic Indicators: </b>Indigenous Population;Sex

<b>SORN: </b>Not Applicable

<b>Data Use Agreement: </b>Yes

<b>Data Use Agreement Location: </b>https://www.icpsr.umich.edu/web/ICPSR/studies/31581/datadocumentation

<b>Granularity: </b>Childcare Providers;Individual

<b>Spatial: </b>States

<b>Geocoding: </b>Unavailable
Weekly Differences in Cumulative Respiratory Syncytial Virus (RSV) Vaccination Coverage and Comparison, Overall, by Jurisdiction, Among Adults 75 Years and Older and Adults 50-74 Years with High-Risk Conditions

• Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 50-74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction 

• Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 50-74 years with high risk conditions are calculated using data from the National Immunization Survey - Fall Respiratory Virus Module (NIS–FRVM) (https://www.cdc.gov/nis/about/). The NIS-FRVM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. 

• In June 2025, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged 50–74 years who are at increased risk for severe RSV disease may receive a single dose of an RSV vaccine. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older. The data below capture ever receiving a dose of an RSV vaccine by adults 50 years and older. 

• The NIS-FRVM data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel (https://www.cdc.gov/respiratory-viruses/data/index.html). This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
Patent AT-E401561-T1: [Translated] TIRE PRESSURE MONITORING DEVICE

A low tire pressure monitoring device that is affixed to a tire valve stem and methods of using the same. The monitoring device comprises a housing having a counter-pressure chamber, a main pressure chamber, and a flexible membrane that separates the two chambers. The monitoring device is calibrated by trapping the tire's initial air pressure in the counter-pressure chamber. The air pressure within the main pressure chamber is equivalent to the air pressure within the tire. Over the course of time, the air pressure within the tire and concomitantly the air pressure within the main pressure chamber decreases. When the pressure in the counter-pressure is greater than the pressure within the main pressure chamber, the flexible membrane touches and completes an electrical circuit and a warning signal is emitted.
Emergency Temporary Shelters - Intake From Landing Zone

Under <a href="https://chicityclerkelms.chicago.gov/Matter/?matterId=6DEAA6D8-D0E6-EE11-904C-001DD806E058" target="_blank">SO2024-0008386</a>, passed by City Council on 4/17/2024, the Department of Family and Support Services publishes data on the City-operated and City-funded emergency new arrivals shelters. This dataset shows the total number of migrants who arrived at each shelter each two-week period from the Landing Zone. The Landing Zone is the City's centralized location for welcoming new arrivals and triaging for shelter placement, when available. In some cases,  migrants previously exited a shelter (not necessarily the same one) under the <a href="https://www.chicago.gov/city/en/sites/texas-new-arrivals/home/faqs.html" target="_blank">Limited Stay Policy</a>.
Trends in Worker Hearing Loss by Industry Sector, 1981-2010

Background: The purpose of this study was to estimate the incidence and prevalence of hearing loss for noise-exposed U.S. workers by industry sector and 5-year time period, covering 30 years.

Methods: Audiograms for 1.8 million workers from 1981-2010 were examined. Incidence and prevalence were estimated by industry sector and time period. The adjusted risk of incident hearing loss within each time period and industry sector as compared with a reference time period was also estimated.

Results: The adjusted risk for incident hearing loss decreased over time when all industry sectors were combined. However, the risk remained high for workers in Healthcare and Social Assistance, and the prevalence was consistently high for Mining and Construction workers.

Conclusions: While progress has been made in reducing the risk of incident hearing loss within most industry sectors, additional efforts are needed within Mining, Construction and Healthcare and Social Assistance.
Premarket Notifications (510(k)s)

Medical device manufacturers are required to submit a premarket notification or 510(k) if they intend to introduce a device into commercial distribution for the first time or reintroduce a device that will be significantly changed or modified to the extent that its safety or effectiveness could be affected. This database of releasable 510(k)s can be searched by 510(k) number, applicant, device name or FDA product code. Summaries of safety and effectiveness information is available via the web interface for more recent records.
Patent AT-E401201-T1: [Translated] SCREEN PRINTABLE ELECTROLUMINescent POLYMER INK

The addition of a variety of additives to a soluble electroluminescent polymer in solution is used to improve the printability and performance of screen printed light-emitting polymer-based devices. Examples of such additives include transparent polymers, gel-retarders, high viscosity liquids, organic and inorganic salts, and oxide nanoparticles. The additives are used to control the viscosity of the electroluminescent polymer ink, to decrease the solvent evaporation rate, and to improve the ink consistency and working time. In addition, these additives can improve the charge injection and power efficiency of light emitting devices manufactured from the screen printable electroluminescent polymer ink.
States Categorized into Five Groups from Lowest to Highest Estimate, by Age Group: Percentages, Annual Averages Based on 2019 and 2020 NSDUHs

State estimates for these years are no longer available due to methodological concerns with combining 2019 and 2020 data. We apologize for any inconvenience or confusion this may causeBecause of the COVID-19 pandemic, most respondents answered the survey via the web in Quarter 4 of 2020, even though all responses in Quarter 1 were from in-person interviews. It is known that people may respond to the survey differently while taking it online, thus introducing what is called a mode effect.When the state estimates were released, it was assumed that the mode effect was similar for different groups of people. However, later analyses have shown that this assumption should not be made. Because of these analyses, along with concerns about the rapid societal changes in 2020, it was determined that averages across the two years could be misleading.For more detail on this decision, see the 2019-2020state data page.
Ensuring competency in end-of-life care: controlling symptoms

Background
          Palliative medicine is assuming an increasingly important role in patient care. The Education for Physicians in End-of-life Care (EPEC) Project is an ambitious program to increase core palliative care skills for all physicians. It is not intended to transmit specialty level competencies in palliative care.
        
        
          Method
          The EPEC Curriculum was developed to be a comprehensive syllabus including trainer notes, multiple approaches to teaching the material, slides, and videos of clinical encounters to trigger discussion are provided. The content was developed through a combination of expert opinion, participant feedback and selected literature review. Content development was guided by the goal of teaching core competencies not included in the training of generalist and non-palliative medicine specialist physicians.
        
        
          Results
          Whole patient assessment forms the basis for good symptom control. Approaches to the medical management of pain, depression, anxiety, breathlessness (dyspnea), nausea/vomiting, constipation, fatigue/weakness and the symptoms common during the last hours of life are described.
        
        
          Conclusion
          While some physicians will have specialist palliative care services upon which to call, most in the world will need to provide the initial approaches to symptom control at the end-of-life.
Compound 527733: Propanoic acid, 3-bromo-2-chloro, isopropyl ester

Chemical compound data from PubChem database. IUPAC Name: propan-2-yl 3-bromo-2-chloropropanoate. Molecular Formula: C6H10BrClO2. Molecular Weight: 229.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525271: N'-(3-methoxy-phenyl)-N,N-dimethyl-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-methoxyphenyl)-N,N-dimethylethanimidamide. Molecular Formula: C11H16N2O. Molecular Weight: 192.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Managed Care Individual Provider Network Data: June 30, 2016

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects individual provider data. Provider Network Data System information is self-reported. For more information, check out http://www.health.ny.gov/health_care/managed_care/.
Compound 527042: N-cyclohexyl-N-methyl-benzamide

Chemical compound data from PubChem database. IUPAC Name: N-cyclohexyl-N-methylbenzamide. Molecular Formula: C14H19NO. Molecular Weight: 217.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Benefits and Cost Sharing PUF - PY2019

The Benefits and Cost Sharing PUF (BenCS-PUF) is one of the files that make up the Marketplace PUF. The BenCS-PUF contains plan-level data on essential health benefits, coverage limits, and cost sharing for each QHP and SADP. These data either originate from the Plans &amp; Benefits template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).
NNDSS - Table II. Invasive pneumococcal disease, age <5

NNDSS - Table II. Invasive pneumococcal disease, age <5 - 2018. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states or territory.

Note:

This table contains provisional cases of selected national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up.  Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:

C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable. —: No reported cases. N: Not reportable. NA:  Not Available.  NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

* Case counts for reporting years 2017 and 2018 are provisional and subject to change. Data for years 2013 through 2016 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.  

† Includes drug resistant and susceptible cases of invasive pneumococcal disease.
2014 CMHS Uniform Reporting System (URS) Table for New Jersey

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for new Jersey. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
2013 CMHS Uniform Reporting System (URS) Tables for District of Columbia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Districtg of Columbia for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E401374-T1: [Translated] BIODEGRADABLE ALIPHATIC-AROMATIC COPOLYESTERS

Biodegradable aliphatic/aromatic copolyester comprising 50 to 60 mol% of an aromatic dicarboxylic acid and 40 to 50 mol% of an aliphatic acid, at least 90% of which is a long-chain dicarboxylic acid (LCDA) of natural origin selected from azelaic acid, sebacic acid, brassylic acid or mixtures thereof; and a diol component.
Compound 525871: N,N-Dimethyl-N'-(3-bromophenyl)-pivalamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-bromophenyl)-N,N,2,2-tetramethylpropanimidamide. Molecular Formula: C13H19BrN2. Molecular Weight: 283.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Well Being Index

The Gallup-Healthways Well-Being Index is the first-ever daily assessment of U.S. residents' health and well-being. By interviewing at least 1,000 U.S. adults every day, the Well-Being Index provides real-time measurement and insights needed to improve health, increase productivity, and lower healthcare costs.
MANY CSV DATA SET FILES HERE

Public and private sector leaders use data on life evaluation, physical health, emotional health, healthy behavior, work environment, and basic access to develop and prioritize strategies to help their communities thrive and grow. Journalists, academics, and medical experts benefit from this unprecedented resource of health statistics and behavioral economic data to inform their research and reporting.
American Indian and Alaska Native Head Start Family and Child Experiences Survey 2019 (AIAN FACES 2019)

AIAN FACES 2019 sought to (1) describe the strengths and needs of all children in Region XI, (2) provide an accurate picture of all children and families who participate in Region XI (AIAN and non-AIAN), and (3) understand the cultural and linguistic experiences of Native children and families in Region XI AIAN Head Start.

<b>Units of Response: </b>Head Start Programs, Head Start Classroom/Teacher, Head Start Children, Head Start Families, Head Start Centers

<b>Type of Data: </b>Evaluation

<b>Tribal Data: </b>Yes

<b>Periodicity: </b>One-time

<b>Demographic Indicators: </b>Disability;Ethnicity;Household Income;Household Size;Housing Status;Indigenous Population;Race;Sex

<b>SORN: </b>https://www.federalregister.gov/documents/2022/09/19/2022-20139/privacy-act-of-1974-system-of-records

<b>Data Use Agreement: </b>Yes

<b>Data Use Agreement Location: </b>https://www.childandfamilydataarchive.org/cfda/archives/cfda/studies/38028/datadocumentation

<b>Granularity: </b>Classroom;Family;Individual;Region

<b>Spatial: </b>United States

<b>Geocoding: </b>Unavailable
Phoenix: Drug-Related Emergency Department Visits, 2004-2011 - Illicits (excluding alcohol)

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving illicit drugs for the Phoenix metropolitan area, covering 2004-2011. These visits involve the use of drugs that have limited or no therapeutic value and are generally illegal if taken without a prescription. It also includes visits involving the inhalation of substances for their psychoactive properties (e.g., sniffing model airplane glue).
Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States

Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States Vaccinations 

• Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html)  

o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June).  

• Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView:  https://www.cdc.gov/flu/fluvaxview/index.htm.
Behavioral Health Barometer: Oklahoma, 2014

This is a behavioral health report for the state of Oklahoma. It uses the  National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use , youth mental health and treatment, adult mental health and treatment, substance use, substance use treatment, and medicare enrollees for the years 2009 to 2013.
Compound 529100: 7-Methyl-4H-pyrido[1,2-a]pyrimidin-4-one

Chemical compound data from PubChem database. IUPAC Name: 7-methylpyrido[1,2-a]pyrimidin-4-one. Molecular Formula: C9H8N2O. Molecular Weight: 160.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530383: Acetophenone, 4-hydroxy-3-methoxy, O-methyloxime

Chemical compound data from PubChem database. IUPAC Name: 2-methoxy-4-(N-methoxy-C-methylcarbonimidoyl)phenol. Molecular Formula: C10H13NO3. Molecular Weight: 195.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400345-T1: [Translated] WASTE SEPARATION AND FILTRATION SYSTEM

The invention provides a debris separation-filtration unit comprising a housing; an inlet that receives debris-laden air delivers the air in a tangential, centrifugal airflow-forming manner to the interior of housing; an inner shell that includes a number of airflow passageways; and a debris-capturing filter, the sides of which filter are at least substantially surrounded by the inner shell. Due to the formation of the centrifugal airflow and presence of the inner shell in the housing, only a portion of the debris particles entering the unit come in contact with the filter. The invention also provides debris collection, separation, and filtration systems comprising one or more of the separation-filtration units of the invention; debris collection vehicles comprising one or more of such units or systems; and related methods of collecting, separating, and filtering debris.
Household Pulse Survey (HPS): COVID-19 Vaccination among People with Disabilities

Household Pulse Survey (HPS): HPS is a rapid-response survey of adults ages ≥18 years led by the U.S. Census Bureau, in partnership with seven other federal statistical agencies, to measure household experiences during the COVID-19 pandemic. Detailed information on probability sampling using the U.S. Census Bureau’s Master Address File, questionnaires, response rates, and bias assessment is available on the Census Bureau website (https://www.census.gov/data/experimental-data-products/household-pulse-survey.html).

Data from adults ages ≥18 years and older are collected by a 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). Data are weighted to represent total persons ages 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Data from adults ages ≥18 years and older are collected by 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). For more information on this survey, see https://www.census.gov/programs-surveys/household-pulse-survey.html.

Data are weighted to represent total persons ages 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Responses in the Household Pulse Survey (https://www.census.gov/programs-surveys/household-pulse-survey.html) are self-reported. Estimates of vaccination coverage may differ from vaccine administration data reported at COVID-19 Vaccinations in the United States (https://covid.cdc.gov/covid-data-tracker/#vaccinations).